Aviva Gross

Statistics

Publications

Citations

1.1K

H-Index

Active since

1998

Affiliations

Rappaport Family Institute for Research in the Medical Sciences(Current)

Teva Pharmaceuticals (Israel)

Technion – Israel Institute of Technology

Hebrew University of Jerusalem

Aviva Gross is an author at Rappaport Family Institute for Research in the Medical Sciences specializing in neuropharmacology, pharmacology, and medicine.

Publications per year

1998–2018

Publications

Rasagiline [N‐propargyl‐1R(+)‐aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

Moussa B. H. Youdim, Aviva Gross, J. P. M. Finberg · British Journal of Pharmacology · 2001 · 340 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's Disease

Jeffrey Sterling, Yaacov Herzig, Tamar Goren et al. · Journal of Medicinal Chemistry · 2002 · 251 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>O<sub>2</sub> and 6‐hydroxydopamine

Michael Gassen, Aviva Gross, Moussa B. H. Youdim · Movement Disorders · 1998 · 134 citations

Medicine, Neuroscience, Pharmacology +17

TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer’s disease

Marta Weinstock, Corina Bejar, R.-H. Wang et al. · 2000 · 117 citations

Medicine, Neuroscience, Pharmacology +17

Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects

Orit Cohen‐Barak, Jacqueline Wildeman, Jeroen van de Wetering et al. · The Journal of Clinical Pharmacology · 2014 · 63 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

1–5 of 13